UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by ProVise Management Group LLC

ProVise Management Group LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,256 shares of the healthcare conglomerate’s stock after buying an additional 155 shares during the period. ProVise Management Group LLC’s holdings in UnitedHealth Group were worth $2,767,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in UNH. WealthPlan Investment Management LLC grew its holdings in shares of UnitedHealth Group by 774.0% during the third quarter. WealthPlan Investment Management LLC now owns 673 shares of the healthcare conglomerate’s stock worth $339,000 after buying an additional 596 shares in the last quarter. Millington Financial Advisors LLC increased its stake in UnitedHealth Group by 2.7% in the third quarter. Millington Financial Advisors LLC now owns 3,156 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 82 shares during the last quarter. Parsons Capital Management Inc. RI increased its position in UnitedHealth Group by 17.1% during the third quarter. Parsons Capital Management Inc. RI now owns 4,343 shares of the healthcare conglomerate’s stock worth $2,190,000 after purchasing an additional 635 shares during the last quarter. XML Financial LLC boosted its holdings in shares of UnitedHealth Group by 15.5% in the 3rd quarter. XML Financial LLC now owns 3,297 shares of the healthcare conglomerate’s stock valued at $1,662,000 after purchasing an additional 442 shares during the last quarter. Finally, Mawer Investment Management Ltd. raised its position in shares of UnitedHealth Group by 75.0% in the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock worth $1,014,002,000 after buying an additional 862,024 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Piper Sandler increased their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. TD Cowen decreased their target price on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Three research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $8.66 during trading on Friday, reaching $508.17. 2,528,228 shares of the company’s stock traded hands, compared to its average volume of 2,805,318. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The company has a 50 day moving average of $489.23 and a 200-day moving average of $510.92. The stock has a market capitalization of $467.71 billion, a P/E ratio of 31.06, a price-to-earnings-growth ratio of 1.50 and a beta of 0.55. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the previous year, the business earned $6.26 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.